FLOW TRADERS U.S. LLC

Position in NVO — Novo Nordisk A S

CIK 1466697 NEW YORK, NY

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$748,055

-$288,662 QoQ

Shares Held

15,604

-44.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#594

of 1,348 holders

Holding Since

Mar 2020

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FLOW TRADERS U.S. LLC holds $4,757,022 across 6 Drug Manufacturers - General names. NVO ranks #4 (15.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GSK	GSK plc	25,703	$1,347,351
2	LLY	ELI LILLY & Co	909	$1,090,281
3	AMGN	Amgen Inc	2,568	$929,924
4	NVO	Novo Nordisk A S This page	15,604	$748,055
5	ABBV	AbbVie Inc.	1,352	$340,217
6	GILD	Gilead Sciences, Inc.	2,384	$301,194

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$748,055	15,604	-44.7%	Shares	Sole	2026-08-14
2026-03-31	$1,036,717	28,210	-12.4%	Shares	Sole	2026-05-15
2025-12-31	$1,638,132	32,196	-21.7%	Shares	Sole	2026-02-13
2025-09-30	$2,281,804	41,121	+535.9%	Shares	Sole	2025-11-14
2025-06-30	$446,352	6,467	-72.4%	Shares	Sole	2025-08-13
2025-03-31	$1,629,340	23,464	-5.4%	Shares	Sole	2025-05-14
2024-09-30	$2,951,983	24,792	+788.9%	Shares	Sole	2024-11-14
2024-06-30	$398,101	2,789	-89.4%	Shares	Sole	2024-08-14
2024-03-31	$3,375,764	26,291	+6.4%	Shares	Sole	2024-05-15
2023-12-31	$2,555,111	24,699	+587.6%	Shares	Sole	2024-02-14
2022-09-30	$357,870	3,592	+96.9%	Shares	Sole	2022-11-14
2022-03-31	$202,555	1,824	-70.7%	Shares	Sole	2022-05-13
2021-12-31	$697,872	6,231	+89.2%	Shares	Sole	2022-02-14
2021-09-30	$316,160	3,293	-84.9%	Shares	Sole	2021-11-15
2021-06-30	$1,827,693	21,818	+464.4%	Shares	Sole	2021-08-24
2020-09-30	$268,416	3,866	-21.8%	Shares	Sole	2020-11-16
2020-03-31	$297,448	4,941	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.